Know the dangers of Victoza and other diabetes medicines
Four new studies published in the New England Journal of Medicine show that those with diabetes who are using certain medications to decrease their risk of stroke and heart attack are not successful. One observed that using antihypertensives to lower systolic blood pressure did not reduce the risk of cardiac complications. Another found no benefit in adding remedies to raise HDL (good) cholesterol. In addition, no cardiac benefit was associated with two medications used to decrease hyperglycemia.
Yes, cardiovascular disease is the greatest concern of the diabetic, but the remedies are not being the answer to this problem.
Between 1999> and 2007 Avandia is estimated to have caused 83,000 unnecessary heart attacks.
On September 23, 2010, an article finally announced that the Food and Drug Administration (FDA) decided to investigate Avandia (drug for diabetes).
Between 1999> and 2007, Avandia is estimated to have caused 83,000 unnecessary heart attacks. This is an expensive price for a disease that could be treated in a more natural and therapeutic way. In addition, it is related to a 43% higher risk of heart attack and 64% of death due to cardiovascular risk compared to patients treated with other methods.
Now, this medication will only be prescribed if all others fail to control the glycemia. Individuals who are already on medication and have had good results may continue to use it, provided they are aware of their risks and under medical supervision.
Diabetes has increased more than 700% in the past 50 years. Contrary to the FDA, the British regulator has considered the drug Avandia very risky, stating that it brings with it a very risky situation.
But the FDA is not picking up too lightly. more risks than benefits. The result of such a statement was the abandonment of the remedy by 90,000 Britons in a single month. Another example that proved a misconception of traditional medicine was Viox.
Diabetes has increased more than 700% in the last 50 years. Today, 54% of Brazilians are pre-diabetic or diabetic. As there is still no cure for evil, conventional medicine treats only the consequences of the disease. Still, the medications used can also not be considered 100% safe.
So, the best attitude toward the disease are prevention measures that include a balanced diet and regular exercise.
Diabetes - Photo Getty Images
Sitagliptin (Januvia), Exenatide (Byetta) and pancreatic cancer
According to the National Cancer Institute
, pancreatic cancer is the 10th most common type in the United States. Known as a "silent killer," it does not show any early-stage symptoms, only manifesting itself when the disease is well advanced. According to a recent study published in the American Journal of Gastroenterology , some medications used to control diabetes may be increasing the risk of developing this type of cancer
According to researchers at the University of California ( ) in the United States, adverse events reported between patients using Sitagliptin (Januvia) and Exenatide (Byetta) between 2004 and 2009 are of concern. The results showed that the drug increases sixfold the likelihood of one person having pancreatitis compared to four other disease control therapies. Victoza - Photo Getty Images
They also found that patients taking Sitagliptin are 2.7 times more likely to develop pancreatic cancer and those taking Exenatide are 2.9 times more likely to develop the disease. Both Sitagliptin and Exenatide increase the action of the hormone GLP-1 that lowers blood sugar. However, one study also suggested a link between this type of drug and pancreatitis. Victoza (Liraglutida) and thyroid and pancreatic cancer
Launched in Brazil four months ago, Victosa (Liraglutida), which is the hormone GLP -1, is being used both for the treatment of diabetes and for the struggle to lose weight by people without the disease.
GLP-1 is the main hormone associated with the sensation of satiety and the insulin-producing mechanism, but it has
Both Sitagliptin and Exenatide increase the action of the blood-sugar-lowering hormone GLP-1.
Data show increased risk of thyroid cancer in rats and mice who received the medicine. It is not known if the same risk exists for people.
Another fact that draws attention is that in 2010 the manufacturer of this medication was accused of breaking the code of conduct of the Association of British Pharmaceutical Industry by minimizing the side effects of the drug.
Treating Diabetes Effectively Without Medications
Three guidelines are basic to successfully treating diabetes: regain your insulin / leptin sensitivity, normalize your weight, and regulate your blood pressure. To do this, here are some tips:
Limit or eliminate sugars and grains from your food, especially fructose, as they have an unfavorable action on insulin sensitivity. You should eliminate even the healthy grains. That means avoiding breads, pasta, cereals, rice, potatoes and corn. Do not eat fruit until your blood glucose is under control
Follow a meal that is consistent with your metabolic type;
3. Exercise regularly
4. Avoid trans fat because they alter insulin sensitivity and increase cellular oxidation especially in the pancreas;
5. Eat too much omega-3 from animal sources, as it improves insulin sensitivity;
Optimize vitamin D levels Recent studies show that by having good levels of vitamin D you can have a powerful effect on your blood pressure normalization; 8.
Control your insulin by avoiding fasting 9.
Take care of your intestinal flora. With this, you will be treating type 2 diabetes and reducing the chances of children developing type 1 diabetes.
HEALTH , six brands of coconut water sold in the national territory, and identified that some statements on the label, such as "100% coconut palm", "without preservatives" and "without added sugar", may induce the consumer to misinterpret The brands Do Bem, Kero Coco, Obrigado, Coco do Vale, Sococo and Ducoco were evaluated in several aspects such as labeling, acidity, presence of sugar and microorganisms and sensorial analysis.
Women who take estrogen-only hormone replacement therapy to relieve climacteric symptoms may also be reducing their risk of a common form of glaucoma. This is what a research developed by scientists at the University of Michigan, and published online January 30 in the journal JAMA Ophthalmology. The authors evaluated information on more than 152,000 women.